Interestingly, we found that both PI3K/Akt and Wnt/β-catenin pathways were slightly regulated by the combination drugs, hinting for the possibility that the two pathways were important for RAS-mutant colon cancer cells. Here, PIK3CA is linked to colonic neoplasm.